| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |